Year: 2020
Type: editorial
Abstract: March of 2020, we found ourselves in the midst of a global SARs-CoV-2 pandemic with severe health consequences and an alarming transmission rate.Central to the response to slow infectivity were the limitation of movement of people, incorporation of physical distancing, and use of personal protective equipment (PPE).These measures were implemented to different extents across a variety of industries.Here, we address the impact, challenges, and some steps taken by biomedical shared resource laboratories (also called research core facilities, or Cores) in areas that include operations (ramp down, closure, and ramp up plans), staffing (including staff training and engagement), productivity (including impact of supply chain issues), and financial implications.We focus here on an administrative viewpoint, and particularly on flow cytometry shared resources (Flow Cores).The guidance presented represents the collective experience of the authors.However, many of the pandemic-related issues and lessons learned can apply to all Cores and are also at various stages of implementation at other institutions.
Source: Cytometry Part A
DOI: 10.1002/cyto.a.24263
Institutions: University of California, Davis, University of Pennsylvania, Johns Hopkins University, University of Miami, Sylvester Comprehensive Cancer Center, NYU Langone Health, Instituto Gulbenkian de Ciência, Spanish National Cancer Research Centre, Memorial Sloan Kettering Cancer Center, University of Massachusetts Amherst, Cincinnati Children's Hospital Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3105998514